By Matt Lamers
Canadian medical cannabis exports are surging, driven by licensed producers that are using overseas shipments as a way to establish local partnerships and gain a foothold in foreign markets.
In particular, exports of dried medical marijuana and MMJ oil products from Canada have soared since 2015.
Read More
One of Canada’s biggest cannabis cultivators, Aphria Inc., is partnering with an upstart Canadian producer to build a 1 million-square-foot MJ greenhouse in the Ontario town of Leamington. Aphria (TSE: APH) said in a news release it also is pumping 2 million Canadian dollars ($1.6 million) into its new partner, Nuverra Corp., through a share purchase. Nuuvera […]
Read More
Budding cannabis entrepreneurs in Canada have a new resource to help get their businesses launched, thanks to some established players in the nation’s marijuana industry. Leaf Forward, which claims to be the country’s first cannabis business accelerator program, will provide early stage ancillary businesses with mentoring, networking and learning opportunities. The program doesn’t provide seed […]
Read More
By Matt Lamers
Canadian cannabis companies eyeing the U.S. medical and recreational marijuana markets are finding them fraught with legal and regulatory pitfalls, prompting most of the big licensed producers to shun that country altogether – at least for now.
Read More
By Matt Lamers
Canadian medical marijuana companies are primed to tap what one industry executive calls “insane” growth overseas.
Flush with capital and largely free from American competition, Canadian licensed producers are spreading their wings to gain a first-mover advantage in new markets as more countries legalize marijuana for medical use.
Read More
MedReleaf has joined a growing list of Canadian licensed producers exporting medicinal flower and oil products overseas. The Markham, Ontario-based company on Tuesday said it completed the first-ever shipment of medical cannabis oil to Brazil. It was also the first cannabis-based drug export for MedReleaf, which lists as LEAF on the Toronto Stock Exchange. While the transaction […]
Read More
One of Canada’s stock exchanges has sought to ease concerns it could become harder for investors to trade the shares of Canadian marijuana companies with U.S. assets, saying such businesses can list their stocks provided they meet disclosure rules and other listing standards. The Canadian Securities Exchange is “open for business” for MMJ companies with cannabis […]
Read More
Shares of the five licensed cannabis companies that trade on the the Toronto Stock Exchange were down Friday after reports surfaced that it could become harder for investors to deal in the shares of Canadian marijuana firms with U.S. assets. According to the Globe and Mail, Canadian Depository for Securities (CDS) – a clearinghouse owned by the […]
Read More
Manitoba’s medical marijuana businesses want to ensure that local MJ businesses get a crack at participating in the province’s emerging recreational cannabis market. MMJ retailers and licensed producers (LP) in Winnipeg are urging the provincial government to adopt a “made in Manitoba” business model to prevent large, established MJ companies from monopolizing the market after […]
Read More
By Matt Lamers Canadian marijuana producers confront major changes that promise to reshape the nation’s MJ industry, ranging from the planned rollout of recreational cannabis next summer to a potential deluge of new growers entering the market. Among the companies navigating that shifting landscape is Markham, Ontario-based MedReleaf, one of Canada’s most profitable cannabis producers.
Read More
The number of registered medical marijuana patients in Alberta doubled, and the number of doctors prescribing MMJ rose 50% in the first quarter of this year, indicating the drug is becoming more accessible to the province’s 4.1 million people. The increases bode well for Canada’s MMJ companies and offer a sneak preview of business prospects for […]
Read More
Cannabis Wheaton received approval from the TSX Venture Exchange to purchase 15 million Canadian dollars ($12 million) of ABcann shares. The transaction is part of a larger CA$30 million investment Cannabis Wheaton is making to fund the construction of a 50,000-square-foot (4,600-square meter) expansion at ABcann’s proposed Kimmett cannabis cultivation facility in Napanee, Ontario. After the […]
Read More
